Encompass Health Corporation
EHC
$107.93
-$1.02-0.94%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 15.49% | -10.98% | -6.20% | 25.31% | 11.74% |
| Total Depreciation and Amortization | 4.85% | 3.13% | 0.88% | 1.54% | -0.51% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 49.75% | 15.36% | -20.34% | -2.97% | 38.40% |
| Change in Net Operating Assets | 672.22% | 146.15% | 48.00% | -367.86% | -91.38% |
| Cash from Operations | 27.77% | 0.22% | -6.38% | 3.52% | 4.11% |
| Capital Expenditure | -22.55% | -19.25% | 3.80% | 17.92% | -34.71% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 28.87% | -67.06% | -284.78% | 192.00% | 64.29% |
| Cash from Investing | -18.93% | -21.70% | -4.35% | 22.19% | -26.13% |
| Total Debt Issued | -12.50% | -- | -100.00% | 100.00% | 100.00% |
| Total Debt Repaid | 74.13% | -387.00% | 72.13% | 31.86% | 24.98% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -206.83% | -0.40% | 52.22% | -592.00% | -10.29% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -11.76% | 0.58% | 5.00% | -5.88% | -13.33% |
| Other Financing Activities | -2.81% | -64.23% | 35.80% | -3.85% | -152.85% |
| Cash from Financing | 13.96% | -25.50% | 30.83% | 13.59% | -68.60% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 121.05% | -399.32% | 4,966.67% | 99.60% | -551.19% |